An Exploratory Investigation of a Supplement to Support Student Learning

JoySpring

Status: Completed

Conditions: Mental Fatigue; Concentration Ability Impaired

Treatments: Dietary Supplement: GeniusDrops

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05528094

20246

Details and patient eligibility

About

In this trial, the herbal supplement (GeniusDrops) will be tested to see the effects it has on the dependent variables of interest. Participants will take the supplement twice a day for a month and respond to surveys at study baseline, midpoint, and the conclusion of the study. The findings of this study will be used for marketing materials and to inform future trials using the supplement.

Enrollment: 38 patients

Sex: All

Ages: 5 to 12 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Provision of signed and dated informed consent form and a parental assent form
• Must be experiencing issues with focus, mood, and memory
• Must be looking to improve classroom performance
• Gets easily distracted

Exclusion criteria

• Diagnosis of ADD or ADHD
• Currently taking a prescription medication meant to treat ADD or ADHD
• Diagnosed with additional conditions that would not allow them to adhere to the protocol.
• Willing to take a supplement targeting improving mood, concentration, and focus

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

38 participants in 1 patient group

GeniusDrops

Experimental group

Description:

Once participants have signed the consent and assent, they will take the baseline survey to gather information about their ability to focus and concentration. Once in the study, participants will be asked to take two dropperfuls of the test product (Genius Drops) twice daily. The participants can take the dropperful directly or add it to drinks/snacks. Participants will need to be in school during the entirety of the study. Participants will take a subsequent survey after two weeks in the trial and then another survey at the end of the trial.

Treatment:

Dietary Supplement: GeniusDrops